# | ||||
---|---|---|---|---|
1 | SUPPRESSTEM Testing and validation of bispecific antibody combinations targeting treatment-resistant cancer stem cells using organoid-based screening tools: a new drug discovery paradigm | 2013 | 7˙756˙658.00 | 5˙953˙319.00 |
L'Ente merus bv partecipato anche in questi progetti.